Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Kidney Calculi | 160 | 2023 | 341 | 17.460 |
Why?
|
Calcium Oxalate | 100 | 2023 | 186 | 8.330 |
Why?
|
Calcium | 104 | 2023 | 1172 | 5.350 |
Why?
|
Hypercalciuria | 15 | 2023 | 47 | 3.640 |
Why?
|
Kidney | 44 | 2023 | 1145 | 3.560 |
Why?
|
Calcium Phosphates | 32 | 2020 | 77 | 3.450 |
Why?
|
Urine | 20 | 2019 | 89 | 2.360 |
Why?
|
Acid-Base Equilibrium | 6 | 2021 | 33 | 2.110 |
Why?
|
Kidney Medulla | 21 | 2023 | 81 | 2.010 |
Why?
|
Urinary Calculi | 17 | 2009 | 46 | 1.950 |
Why?
|
Uric Acid | 41 | 2020 | 136 | 1.850 |
Why?
|
Kidney Tubules, Proximal | 9 | 2019 | 60 | 1.830 |
Why?
|
Oxalates | 20 | 2022 | 48 | 1.650 |
Why?
|
Crystallization | 45 | 2019 | 210 | 1.530 |
Why?
|
Kidney Tubules | 15 | 2020 | 92 | 1.450 |
Why?
|
Kidney Failure, Chronic | 12 | 2019 | 413 | 1.450 |
Why?
|
Hydrogen-Ion Concentration | 34 | 2020 | 499 | 1.260 |
Why?
|
Renal Insufficiency, Chronic | 4 | 2022 | 219 | 1.190 |
Why?
|
Nephrolithiasis | 5 | 2016 | 23 | 1.180 |
Why?
|
Humans | 234 | 2023 | 89063 | 1.140 |
Why?
|
Hyperoxaluria | 8 | 2022 | 26 | 1.110 |
Why?
|
Parathyroid Hormone | 26 | 2023 | 216 | 1.100 |
Why?
|
Glycoproteins | 19 | 1994 | 234 | 1.100 |
Why?
|
Cystinuria | 8 | 2010 | 13 | 1.090 |
Why?
|
Male | 154 | 2021 | 42251 | 1.080 |
Why?
|
Calcium, Dietary | 21 | 2023 | 64 | 1.010 |
Why?
|
Phosphorus | 21 | 2015 | 117 | 0.950 |
Why?
|
Female | 141 | 2021 | 46011 | 0.940 |
Why?
|
Middle Aged | 84 | 2021 | 25863 | 0.930 |
Why?
|
Glomerular Filtration Rate | 12 | 2019 | 275 | 0.900 |
Why?
|
Vitamin D Deficiency | 2 | 2022 | 103 | 0.880 |
Why?
|
Calcitriol | 25 | 2008 | 173 | 0.870 |
Why?
|
Renal Dialysis | 6 | 2019 | 335 | 0.860 |
Why?
|
Arteriovenous Shunt, Surgical | 3 | 2016 | 71 | 0.860 |
Why?
|
Creatinine | 18 | 2021 | 293 | 0.860 |
Why?
|
Sulfates | 2 | 2021 | 57 | 0.810 |
Why?
|
Adult | 84 | 2021 | 26507 | 0.800 |
Why?
|
Vitamin D | 9 | 2022 | 268 | 0.770 |
Why?
|
Diuretics | 15 | 2013 | 75 | 0.740 |
Why?
|
Diet | 18 | 2019 | 442 | 0.730 |
Why?
|
Aging | 4 | 2021 | 716 | 0.720 |
Why?
|
Acid-Base Imbalance | 1 | 2019 | 4 | 0.700 |
Why?
|
Cystine | 5 | 2010 | 15 | 0.660 |
Why?
|
Postprandial Period | 5 | 2017 | 47 | 0.650 |
Why?
|
Veins | 1 | 2019 | 95 | 0.640 |
Why?
|
Brachiocephalic Veins | 2 | 2009 | 34 | 0.620 |
Why?
|
Risk Factors | 24 | 2020 | 5466 | 0.610 |
Why?
|
Hyperparathyroidism, Secondary | 5 | 2015 | 68 | 0.610 |
Why?
|
Health Status Disparities | 1 | 2020 | 187 | 0.610 |
Why?
|
Uromodulin | 10 | 2023 | 15 | 0.590 |
Why?
|
Thiazides | 3 | 2022 | 16 | 0.590 |
Why?
|
Chlorthalidone | 4 | 2013 | 18 | 0.590 |
Why?
|
Parathyroid Glands | 6 | 2013 | 74 | 0.580 |
Why?
|
Sex Factors | 17 | 2019 | 1063 | 0.570 |
Why?
|
Citric Acid | 8 | 2021 | 38 | 0.560 |
Why?
|
Phosphates | 18 | 2018 | 160 | 0.560 |
Why?
|
Apatites | 9 | 2017 | 19 | 0.550 |
Why?
|
Biomarkers | 9 | 2020 | 1755 | 0.550 |
Why?
|
Brachiocephalic Trunk | 1 | 2016 | 14 | 0.550 |
Why?
|
Medullary Sponge Kidney | 3 | 2015 | 6 | 0.540 |
Why?
|
Citrates | 9 | 2017 | 28 | 0.540 |
Why?
|
Hyperparathyroidism | 14 | 2008 | 67 | 0.520 |
Why?
|
Poetry as Topic | 2 | 2011 | 5 | 0.520 |
Why?
|
Medicine in Literature | 2 | 2011 | 8 | 0.520 |
Why?
|
Specimen Handling | 3 | 2002 | 102 | 0.520 |
Why?
|
Proteinuria | 4 | 2019 | 67 | 0.520 |
Why?
|
Sodium-Hydrogen Exchangers | 2 | 2018 | 77 | 0.520 |
Why?
|
Blood Flow Velocity | 1 | 2016 | 198 | 0.520 |
Why?
|
Aged | 40 | 2020 | 19077 | 0.500 |
Why?
|
Durapatite | 2 | 2014 | 28 | 0.500 |
Why?
|
Hypercalcemia | 8 | 2008 | 60 | 0.490 |
Why?
|
Rats | 33 | 2010 | 4040 | 0.490 |
Why?
|
Receptors, Calcium-Sensing | 3 | 2023 | 14 | 0.480 |
Why?
|
Sodium | 17 | 2022 | 331 | 0.480 |
Why?
|
Phosphoproteins | 2 | 2018 | 261 | 0.480 |
Why?
|
Kidney Diseases | 10 | 2014 | 319 | 0.480 |
Why?
|
Sodium Chloride Symporter Inhibitors | 13 | 2011 | 37 | 0.470 |
Why?
|
Loop of Henle | 6 | 2018 | 11 | 0.460 |
Why?
|
Biopsy | 10 | 2020 | 1182 | 0.460 |
Why?
|
Receptors, Calcitriol | 2 | 2004 | 130 | 0.450 |
Why?
|
Mucoproteins | 8 | 1998 | 14 | 0.450 |
Why?
|
Monocytes | 2 | 2004 | 218 | 0.440 |
Why?
|
Intestinal Absorption | 13 | 2008 | 124 | 0.440 |
Why?
|
Acidosis | 10 | 1986 | 55 | 0.440 |
Why?
|
Osteogenesis | 1 | 2015 | 255 | 0.440 |
Why?
|
Calcium Metabolism Disorders | 9 | 1994 | 14 | 0.430 |
Why?
|
Endoscopy | 6 | 2016 | 348 | 0.420 |
Why?
|
Bone and Bones | 6 | 2006 | 269 | 0.410 |
Why?
|
Osteopontin | 4 | 2010 | 47 | 0.400 |
Why?
|
Algorithms | 2 | 2019 | 1875 | 0.400 |
Why?
|
Nephrostomy, Percutaneous | 7 | 2015 | 32 | 0.390 |
Why?
|
Jejunoileal Bypass | 3 | 2008 | 6 | 0.380 |
Why?
|
Ureteroscopy | 4 | 2022 | 38 | 0.380 |
Why?
|
Animals | 57 | 2015 | 27317 | 0.380 |
Why?
|
Intestine, Small | 4 | 2010 | 299 | 0.380 |
Why?
|
Magnesium | 14 | 2023 | 178 | 0.360 |
Why?
|
Benzothiadiazines | 10 | 1999 | 13 | 0.360 |
Why?
|
Allopurinol | 16 | 2010 | 77 | 0.350 |
Why?
|
Time Factors | 18 | 2017 | 5320 | 0.340 |
Why?
|
Attitude to Health | 1 | 2011 | 222 | 0.340 |
Why?
|
Secondary Prevention | 4 | 2016 | 158 | 0.330 |
Why?
|
Bone Density | 3 | 2006 | 209 | 0.320 |
Why?
|
Obesity | 4 | 2010 | 966 | 0.320 |
Why?
|
X-Ray Microtomography | 4 | 2022 | 89 | 0.320 |
Why?
|
Recurrence | 19 | 2016 | 1140 | 0.310 |
Why?
|
Renal Elimination | 2 | 2020 | 8 | 0.310 |
Why?
|
Diuresis | 4 | 2003 | 26 | 0.300 |
Why?
|
Bariatric Surgery | 2 | 2008 | 195 | 0.300 |
Why?
|
Disease Models, Animal | 3 | 2010 | 2362 | 0.300 |
Why?
|
Case-Control Studies | 8 | 2021 | 1855 | 0.300 |
Why?
|
Fistula | 1 | 2008 | 42 | 0.300 |
Why?
|
Kidney Tubules, Collecting | 5 | 2020 | 24 | 0.290 |
Why?
|
Renal Reabsorption | 2 | 2018 | 7 | 0.290 |
Why?
|
Nephrocalcinosis | 3 | 2015 | 9 | 0.290 |
Why?
|
Constriction, Pathologic | 1 | 2008 | 217 | 0.290 |
Why?
|
Nephrectomy | 8 | 2006 | 293 | 0.290 |
Why?
|
Lithotripsy | 5 | 2016 | 42 | 0.280 |
Why?
|
Stress, Mechanical | 2 | 2019 | 253 | 0.280 |
Why?
|
Bone Resorption | 1 | 2006 | 42 | 0.280 |
Why?
|
Young Adult | 9 | 2019 | 6288 | 0.280 |
Why?
|
Alzheimer Disease | 1 | 2011 | 497 | 0.270 |
Why?
|
Magnesium Compounds | 4 | 2008 | 7 | 0.270 |
Why?
|
Potassium | 11 | 2021 | 253 | 0.270 |
Why?
|
Hyperparathyroidism, Primary | 4 | 2010 | 42 | 0.260 |
Why?
|
Tiopronin | 3 | 2006 | 6 | 0.260 |
Why?
|
Microscopy, Electron, Transmission | 5 | 2014 | 136 | 0.260 |
Why?
|
Penicillamine | 3 | 2001 | 12 | 0.250 |
Why?
|
Kidney Cortex | 4 | 2010 | 34 | 0.240 |
Why?
|
Cholecalciferol | 1 | 2004 | 35 | 0.240 |
Why?
|
Captopril | 2 | 2001 | 20 | 0.240 |
Why?
|
Carbon Dioxide | 8 | 2017 | 202 | 0.240 |
Why?
|
Anions | 2 | 2021 | 31 | 0.230 |
Why?
|
Water-Electrolyte Balance | 3 | 2020 | 67 | 0.230 |
Why?
|
Cohort Studies | 7 | 2018 | 2863 | 0.230 |
Why?
|
Solubility | 5 | 2010 | 179 | 0.230 |
Why?
|
Lipopolysaccharides | 1 | 2004 | 293 | 0.220 |
Why?
|
Sodium, Dietary | 1 | 2022 | 8 | 0.220 |
Why?
|
Down-Regulation | 1 | 2004 | 519 | 0.210 |
Why?
|
Nephrons | 3 | 2008 | 17 | 0.210 |
Why?
|
Follow-Up Studies | 9 | 2012 | 3657 | 0.210 |
Why?
|
Fasting | 3 | 2015 | 163 | 0.210 |
Why?
|
Urodynamics | 2 | 2020 | 122 | 0.200 |
Why?
|
Vitamins | 1 | 2022 | 83 | 0.200 |
Why?
|
Kidney Function Tests | 3 | 2015 | 113 | 0.200 |
Why?
|
Local Area Networks | 1 | 2001 | 1 | 0.200 |
Why?
|
Treatment Outcome | 7 | 2022 | 8203 | 0.190 |
Why?
|
Acidosis, Renal Tubular | 6 | 2010 | 11 | 0.190 |
Why?
|
Hypertension | 6 | 2005 | 741 | 0.190 |
Why?
|
Rats, Sprague-Dawley | 6 | 2006 | 1237 | 0.180 |
Why?
|
Basement Membrane | 3 | 2018 | 55 | 0.180 |
Why?
|
Struvite | 4 | 2008 | 7 | 0.180 |
Why?
|
Patient Compliance | 1 | 2001 | 230 | 0.180 |
Why?
|
Gastrointestinal Absorption | 1 | 2019 | 3 | 0.180 |
Why?
|
Ammonium Compounds | 1 | 2019 | 8 | 0.180 |
Why?
|
Colorimetry | 1 | 1999 | 8 | 0.180 |
Why?
|
Ileostomy | 2 | 2010 | 29 | 0.170 |
Why?
|
Colon | 5 | 1984 | 509 | 0.170 |
Why?
|
Losartan | 1 | 1999 | 30 | 0.170 |
Why?
|
Albuminuria | 1 | 2019 | 48 | 0.170 |
Why?
|
Patient-Specific Modeling | 1 | 2019 | 20 | 0.170 |
Why?
|
Beverages | 1 | 1999 | 17 | 0.170 |
Why?
|
Kidney Tubules, Distal | 3 | 2015 | 19 | 0.160 |
Why?
|
Cytomegalovirus Retinitis | 1 | 1998 | 7 | 0.160 |
Why?
|
Foscarnet | 1 | 1998 | 12 | 0.160 |
Why?
|
Area Under Curve | 1 | 2019 | 337 | 0.160 |
Why?
|
Neural Cell Adhesion Molecules | 1 | 1998 | 15 | 0.160 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 1998 | 33 | 0.160 |
Why?
|
Organic Cation Transport Proteins | 1 | 2018 | 13 | 0.160 |
Why?
|
Hypophosphatemia | 1 | 2018 | 7 | 0.160 |
Why?
|
Sodium-Hydrogen Exchanger 3 | 1 | 2018 | 32 | 0.160 |
Why?
|
PDZ Domains | 1 | 2018 | 14 | 0.160 |
Why?
|
Antihypertensive Agents | 2 | 1999 | 249 | 0.160 |
Why?
|
Organic Anion Transporters | 1 | 2018 | 26 | 0.160 |
Why?
|
Adolescent | 17 | 2019 | 9237 | 0.160 |
Why?
|
Diabetic Nephropathies | 2 | 2009 | 87 | 0.150 |
Why?
|
Calcium-Binding Proteins | 1 | 1998 | 121 | 0.150 |
Why?
|
Trichlormethiazide | 7 | 1988 | 9 | 0.150 |
Why?
|
Calculi | 2 | 2010 | 5 | 0.150 |
Why?
|
Alpha-Globulins | 2 | 2007 | 11 | 0.140 |
Why?
|
Healthy Volunteers | 1 | 2017 | 145 | 0.140 |
Why?
|
Risk Assessment | 3 | 2020 | 2290 | 0.140 |
Why?
|
Retrospective Studies | 5 | 2020 | 9003 | 0.140 |
Why?
|
Prospective Studies | 6 | 2016 | 4273 | 0.140 |
Why?
|
Urinalysis | 1 | 2016 | 31 | 0.140 |
Why?
|
Bicarbonates | 8 | 2019 | 58 | 0.140 |
Why?
|
Quaternary Ammonium Compounds | 4 | 2006 | 80 | 0.140 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2003 | 575 | 0.140 |
Why?
|
Pregnancy Complications | 5 | 1989 | 345 | 0.140 |
Why?
|
Prognosis | 5 | 2015 | 3773 | 0.130 |
Why?
|
Membrane Glycoproteins | 1 | 1998 | 432 | 0.130 |
Why?
|
Ammonium Chloride | 5 | 2015 | 21 | 0.130 |
Why?
|
Cross-Sectional Studies | 3 | 2015 | 1706 | 0.130 |
Why?
|
Chicago | 1 | 2020 | 1423 | 0.130 |
Why?
|
Hemodynamics | 1 | 2019 | 729 | 0.130 |
Why?
|
Kidney Transplantation | 3 | 2009 | 849 | 0.130 |
Why?
|
Nephrolithotomy, Percutaneous | 3 | 2020 | 8 | 0.130 |
Why?
|
Nephrology | 1 | 2015 | 41 | 0.120 |
Why?
|
Antiviral Agents | 1 | 1998 | 475 | 0.120 |
Why?
|
Hydroxyproline | 2 | 2006 | 11 | 0.120 |
Why?
|
Decision Support Systems, Clinical | 1 | 2015 | 105 | 0.120 |
Why?
|
Reference Values | 5 | 1999 | 661 | 0.120 |
Why?
|
Duodenum | 2 | 1986 | 103 | 0.120 |
Why?
|
Serum Albumin | 2 | 1999 | 127 | 0.120 |
Why?
|
Rats, Inbred Strains | 8 | 1986 | 312 | 0.120 |
Why?
|
Hyperoxaluria, Primary | 1 | 2013 | 4 | 0.110 |
Why?
|
Guideline Adherence | 1 | 2015 | 229 | 0.110 |
Why?
|
Age Factors | 6 | 2012 | 1867 | 0.110 |
Why?
|
Lithium | 2 | 2010 | 59 | 0.110 |
Why?
|
Practice Guidelines as Topic | 4 | 2015 | 1043 | 0.110 |
Why?
|
Adrenergic alpha-1 Receptor Antagonists | 1 | 2013 | 8 | 0.110 |
Why?
|
Amino Acids | 9 | 1991 | 245 | 0.110 |
Why?
|
Linear Models | 4 | 2021 | 421 | 0.110 |
Why?
|
United States | 6 | 2015 | 6955 | 0.110 |
Why?
|
Mannitol | 5 | 1986 | 50 | 0.110 |
Why?
|
Calcium Channel Blockers | 1 | 2013 | 121 | 0.110 |
Why?
|
Fluid Therapy | 2 | 2011 | 51 | 0.100 |
Why?
|
Purines | 6 | 1994 | 93 | 0.100 |
Why?
|
Intestinal Mucosa | 4 | 1984 | 805 | 0.100 |
Why?
|
Tomography, X-Ray Computed | 4 | 2017 | 2657 | 0.100 |
Why?
|
Primary Health Care | 1 | 2015 | 351 | 0.100 |
Why?
|
Milk | 1 | 1992 | 53 | 0.100 |
Why?
|
Diet, Protein-Restricted | 1 | 2011 | 3 | 0.100 |
Why?
|
Diet, Sodium-Restricted | 1 | 2011 | 6 | 0.100 |
Why?
|
Kinetics | 9 | 1991 | 1528 | 0.100 |
Why?
|
Siblings | 1 | 2012 | 111 | 0.100 |
Why?
|
Fruit | 1 | 1992 | 76 | 0.100 |
Why?
|
Reproducibility of Results | 4 | 2019 | 2752 | 0.100 |
Why?
|
Observer Variation | 3 | 2019 | 610 | 0.100 |
Why?
|
Osmolar Concentration | 5 | 2007 | 181 | 0.090 |
Why?
|
Mice | 6 | 2010 | 11737 | 0.090 |
Why?
|
Aged, 80 and over | 4 | 2016 | 6777 | 0.090 |
Why?
|
Kidney Concentrating Ability | 1 | 1990 | 9 | 0.090 |
Why?
|
Hyaluronic Acid | 2 | 2008 | 49 | 0.090 |
Why?
|
Body Mass Index | 3 | 2019 | 771 | 0.090 |
Why?
|
Ileum | 3 | 2005 | 160 | 0.090 |
Why?
|
Drug Design | 1 | 2010 | 125 | 0.090 |
Why?
|
Ions | 3 | 2002 | 75 | 0.090 |
Why?
|
Vertebrates | 1 | 1991 | 103 | 0.090 |
Why?
|
Acute Disease | 3 | 2008 | 841 | 0.090 |
Why?
|
Hemodialysis, Home | 1 | 2009 | 1 | 0.090 |
Why?
|
Dialysis Solutions | 1 | 2009 | 7 | 0.090 |
Why?
|
Menopause | 2 | 1989 | 76 | 0.090 |
Why?
|
beta 2-Microglobulin | 1 | 2009 | 24 | 0.090 |
Why?
|
Abdomen | 1 | 2010 | 122 | 0.090 |
Why?
|
Risk | 6 | 2005 | 657 | 0.090 |
Why?
|
1-Carboxyglutamic Acid | 2 | 1987 | 2 | 0.080 |
Why?
|
Child | 13 | 2019 | 7149 | 0.080 |
Why?
|
Femur Neck | 2 | 2006 | 41 | 0.080 |
Why?
|
Models, Biological | 5 | 2015 | 1763 | 0.080 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 1989 | 18 | 0.080 |
Why?
|
Intestines | 2 | 2010 | 416 | 0.080 |
Why?
|
Homeostasis | 3 | 1986 | 413 | 0.080 |
Why?
|
Estrogen Replacement Therapy | 1 | 1989 | 45 | 0.080 |
Why?
|
Epidemiologic Methods | 1 | 2008 | 60 | 0.080 |
Why?
|
Pregnancy Proteins | 1 | 1988 | 38 | 0.080 |
Why?
|
Digestive System Surgical Procedures | 1 | 2010 | 126 | 0.080 |
Why?
|
Spine | 2 | 2006 | 102 | 0.080 |
Why?
|
Donor Selection | 1 | 2009 | 74 | 0.080 |
Why?
|
Insulin | 1 | 2013 | 1146 | 0.080 |
Why?
|
Proteins | 3 | 2006 | 786 | 0.080 |
Why?
|
Phlebography | 1 | 2008 | 66 | 0.080 |
Why?
|
Vascular Diseases | 1 | 1989 | 118 | 0.080 |
Why?
|
Urologists | 2 | 2019 | 29 | 0.080 |
Why?
|
Alkalies | 2 | 2022 | 8 | 0.070 |
Why?
|
Furosemide | 2 | 1986 | 34 | 0.070 |
Why?
|
Pregnancy | 7 | 1989 | 3009 | 0.070 |
Why?
|
Carcinoma, Renal Cell | 1 | 1992 | 435 | 0.070 |
Why?
|
Predictive Value of Tests | 2 | 2016 | 1715 | 0.070 |
Why?
|
Health Surveys | 2 | 2005 | 240 | 0.070 |
Why?
|
Outpatients | 1 | 2008 | 100 | 0.070 |
Why?
|
Kidney Calices | 1 | 2007 | 5 | 0.070 |
Why?
|
Iothalamic Acid | 1 | 2007 | 9 | 0.070 |
Why?
|
Cell Line | 2 | 2004 | 2495 | 0.070 |
Why?
|
Culture Media | 4 | 1989 | 147 | 0.070 |
Why?
|
Immunohistochemistry | 3 | 2007 | 1796 | 0.070 |
Why?
|
Chemistry | 2 | 2001 | 54 | 0.070 |
Why?
|
Dietary Proteins | 1 | 2007 | 30 | 0.070 |
Why?
|
Chemical Phenomena | 2 | 2001 | 72 | 0.070 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 2006 | 269 | 0.070 |
Why?
|
Microvilli | 1 | 2006 | 43 | 0.070 |
Why?
|
Biological Assay | 2 | 2006 | 79 | 0.070 |
Why?
|
Diagnosis, Computer-Assisted | 2 | 2003 | 333 | 0.070 |
Why?
|
X-Ray Diffraction | 3 | 2003 | 126 | 0.070 |
Why?
|
Diverticulum | 1 | 2007 | 45 | 0.070 |
Why?
|
Alkaline Phosphatase | 1 | 2006 | 132 | 0.070 |
Why?
|
Prothrombin | 1 | 2006 | 17 | 0.070 |
Why?
|
CD59 Antigens | 1 | 2006 | 17 | 0.070 |
Why?
|
Calgranulin B | 1 | 2006 | 16 | 0.070 |
Why?
|
Kidney Neoplasms | 1 | 1992 | 635 | 0.070 |
Why?
|
Blood Pressure | 5 | 2015 | 899 | 0.070 |
Why?
|
Cyclic AMP | 5 | 1985 | 274 | 0.070 |
Why?
|
Sex Distribution | 2 | 2004 | 171 | 0.070 |
Why?
|
Absorptiometry, Photon | 1 | 2006 | 99 | 0.070 |
Why?
|
Cell Polarity | 1 | 2006 | 116 | 0.070 |
Why?
|
Chromatography, High Pressure Liquid | 4 | 1991 | 315 | 0.070 |
Why?
|
Family Health | 1 | 2006 | 162 | 0.070 |
Why?
|
Protein Precursors | 1 | 2006 | 140 | 0.060 |
Why?
|
Sialoglycoproteins | 1 | 2005 | 31 | 0.060 |
Why?
|
Glutamates | 1 | 1985 | 89 | 0.060 |
Why?
|
Estrogens | 1 | 1986 | 201 | 0.060 |
Why?
|
Protein Isoforms | 1 | 2006 | 274 | 0.060 |
Why?
|
In Vitro Techniques | 4 | 2002 | 996 | 0.060 |
Why?
|
Hyperkalemia | 1 | 1985 | 13 | 0.060 |
Why?
|
Kidney Pelvis | 1 | 2005 | 51 | 0.060 |
Why?
|
Chemical Precipitation | 3 | 2006 | 18 | 0.060 |
Why?
|
Ricinoleic Acids | 1 | 1984 | 2 | 0.060 |
Why?
|
Deoxycholic Acid | 1 | 1984 | 10 | 0.060 |
Why?
|
Taurocholic Acid | 1 | 1984 | 6 | 0.060 |
Why?
|
Raffinose | 1 | 1984 | 23 | 0.060 |
Why?
|
Collagen | 1 | 2006 | 293 | 0.060 |
Why?
|
Oligosaccharides | 1 | 1984 | 24 | 0.060 |
Why?
|
Fatty Acids, Unsaturated | 1 | 1984 | 28 | 0.060 |
Why?
|
Blotting, Western | 1 | 2006 | 794 | 0.060 |
Why?
|
Skull | 1 | 1986 | 254 | 0.060 |
Why?
|
Pharmaceutical Preparations | 1 | 2005 | 91 | 0.060 |
Why?
|
Multivariate Analysis | 1 | 2007 | 988 | 0.060 |
Why?
|
Minerals | 1 | 1984 | 22 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 1992 | 374 | 0.060 |
Why?
|
Fetus | 1 | 1985 | 232 | 0.060 |
Why?
|
Peptide Fragments | 1 | 2006 | 463 | 0.060 |
Why?
|
Microscopy, Electron | 3 | 2007 | 510 | 0.060 |
Why?
|
Molecular Weight | 5 | 1991 | 331 | 0.060 |
Why?
|
Hydrazines | 3 | 1968 | 31 | 0.060 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2023 | 11 | 0.060 |
Why?
|
Chromatography, DEAE-Cellulose | 3 | 1989 | 20 | 0.060 |
Why?
|
Glucose | 2 | 2023 | 630 | 0.060 |
Why?
|
Ethacrynic Acid | 1 | 1983 | 2 | 0.060 |
Why?
|
Trifluoperazine | 1 | 1983 | 10 | 0.060 |
Why?
|
Drug-Related Side Effects and Adverse Reactions | 1 | 2005 | 202 | 0.050 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2023 | 85 | 0.050 |
Why?
|
Ouabain | 1 | 1983 | 24 | 0.050 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2003 | 27 | 0.050 |
Why?
|
Odds Ratio | 1 | 2005 | 684 | 0.050 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2002 | 141 | 0.050 |
Why?
|
Oxalic Acid | 3 | 1986 | 8 | 0.050 |
Why?
|
New England | 1 | 2001 | 10 | 0.050 |
Why?
|
Somatostatin | 1 | 1981 | 53 | 0.050 |
Why?
|
Buffers | 1 | 2001 | 26 | 0.050 |
Why?
|
Clinical Trials as Topic | 3 | 2013 | 1149 | 0.050 |
Why?
|
Random Allocation | 1 | 2002 | 328 | 0.050 |
Why?
|
Water | 1 | 2023 | 283 | 0.050 |
Why?
|
Midwestern United States | 1 | 2001 | 82 | 0.050 |
Why?
|
Sex Characteristics | 1 | 2003 | 324 | 0.050 |
Why?
|
Spectroscopy, Fourier Transform Infrared | 2 | 2003 | 31 | 0.050 |
Why?
|
Biological Transport, Active | 4 | 1986 | 102 | 0.050 |
Why?
|
Basal Cell Nevus Syndrome | 1 | 1980 | 4 | 0.050 |
Why?
|
Viscosity | 2 | 1991 | 46 | 0.040 |
Why?
|
Cross Reactions | 2 | 1991 | 109 | 0.040 |
Why?
|
Severity of Illness Index | 2 | 2016 | 1837 | 0.040 |
Why?
|
Consensus Development Conferences, NIH as Topic | 1 | 1999 | 1 | 0.040 |
Why?
|
Carcinoma, Basal Cell | 1 | 1980 | 61 | 0.040 |
Why?
|
Zinc Compounds | 1 | 1999 | 6 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2003 | 1067 | 0.040 |
Why?
|
Cyanides | 1 | 1999 | 16 | 0.040 |
Why?
|
Ferrous Compounds | 1 | 1999 | 17 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2023 | 681 | 0.040 |
Why?
|
Nitroprusside | 1 | 1999 | 32 | 0.040 |
Why?
|
Ascorbic Acid | 1 | 1999 | 38 | 0.040 |
Why?
|
Computers | 2 | 1977 | 112 | 0.040 |
Why?
|
Radiography | 4 | 2007 | 809 | 0.040 |
Why?
|
Ammonia | 1 | 2019 | 38 | 0.040 |
Why?
|
Chlorides | 1 | 1999 | 103 | 0.040 |
Why?
|
Citrus | 1 | 1999 | 3 | 0.040 |
Why?
|
Coffee | 1 | 1999 | 10 | 0.040 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 1999 | 42 | 0.040 |
Why?
|
Tea | 1 | 1999 | 21 | 0.040 |
Why?
|
Cysteine | 1 | 1999 | 136 | 0.040 |
Why?
|
Electrophoresis, Disc | 1 | 1998 | 22 | 0.040 |
Why?
|
Child, Preschool | 6 | 2013 | 3717 | 0.040 |
Why?
|
Aquaporin 1 | 1 | 2018 | 4 | 0.040 |
Why?
|
Isoelectric Focusing | 1 | 1998 | 39 | 0.040 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 1998 | 27 | 0.040 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 1999 | 79 | 0.040 |
Why?
|
Postoperative Complications | 2 | 2006 | 2275 | 0.040 |
Why?
|
Mixed Function Oxygenases | 1 | 1999 | 69 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2004 | 2011 | 0.040 |
Why?
|
Community Networks | 1 | 1998 | 30 | 0.040 |
Why?
|
Chromatography, Gel | 2 | 1991 | 103 | 0.040 |
Why?
|
Chloride Channels | 1 | 2018 | 42 | 0.040 |
Why?
|
Transcriptome | 1 | 2023 | 628 | 0.040 |
Why?
|
Leukocyte L1 Antigen Complex | 1 | 1998 | 45 | 0.040 |
Why?
|
Blotting, Northern | 1 | 1998 | 258 | 0.040 |
Why?
|
Gene Library | 1 | 1998 | 133 | 0.040 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 1998 | 33 | 0.040 |
Why?
|
Titrimetry | 1 | 1997 | 15 | 0.040 |
Why?
|
Peptides | 2 | 1978 | 646 | 0.040 |
Why?
|
Alkalosis | 1 | 1977 | 10 | 0.040 |
Why?
|
Polyribonucleotides | 1 | 1977 | 3 | 0.040 |
Why?
|
Kidney Glomerulus | 1 | 1998 | 122 | 0.040 |
Why?
|
Sulfur | 1 | 1977 | 29 | 0.040 |
Why?
|
Artifacts | 1 | 1999 | 245 | 0.040 |
Why?
|
DNA, Complementary | 1 | 1998 | 392 | 0.040 |
Why?
|
Metabolic Clearance Rate | 2 | 1994 | 120 | 0.040 |
Why?
|
Gastrointestinal Tract | 1 | 2019 | 191 | 0.040 |
Why?
|
Christianity | 1 | 1997 | 37 | 0.040 |
Why?
|
Urogenital Abnormalities | 1 | 2016 | 20 | 0.040 |
Why?
|
History, 19th Century | 1 | 1997 | 56 | 0.040 |
Why?
|
Osteoporosis | 1 | 1998 | 122 | 0.040 |
Why?
|
Antimetabolites | 1 | 1996 | 24 | 0.040 |
Why?
|
Nephrologists | 1 | 2016 | 10 | 0.030 |
Why?
|
Electron Probe Microanalysis | 1 | 1996 | 8 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 1999 | 1940 | 0.030 |
Why?
|
Urothelium | 2 | 2007 | 71 | 0.030 |
Why?
|
Transferrins | 1 | 2015 | 3 | 0.030 |
Why?
|
Drug Costs | 1 | 1996 | 63 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2004 | 1975 | 0.030 |
Why?
|
Reminder Systems | 1 | 2015 | 18 | 0.030 |
Why?
|
Cost of Illness | 1 | 1996 | 147 | 0.030 |
Why?
|
Interdisciplinary Communication | 1 | 2016 | 130 | 0.030 |
Why?
|
Double-Blind Method | 1 | 1999 | 1714 | 0.030 |
Why?
|
Least-Squares Analysis | 1 | 2015 | 48 | 0.030 |
Why?
|
Reference Standards | 1 | 2015 | 144 | 0.030 |
Why?
|
Terminal Care | 1 | 1997 | 137 | 0.030 |
Why?
|
Sus scrofa | 1 | 2015 | 50 | 0.030 |
Why?
|
Hemoglobins | 1 | 2015 | 192 | 0.030 |
Why?
|
Forecasting | 1 | 1996 | 305 | 0.030 |
Why?
|
Hydrochlorothiazide | 1 | 1994 | 41 | 0.030 |
Why?
|
Nonlinear Dynamics | 1 | 2015 | 73 | 0.030 |
Why?
|
Dietary Carbohydrates | 1 | 1994 | 39 | 0.030 |
Why?
|
Cholesterol, LDL | 1 | 2015 | 223 | 0.030 |
Why?
|
Consensus | 1 | 2016 | 356 | 0.030 |
Why?
|
Epinephrine | 2 | 1985 | 86 | 0.030 |
Why?
|
Mathematics | 2 | 1988 | 191 | 0.030 |
Why?
|
Dietary Supplements | 1 | 2015 | 125 | 0.030 |
Why?
|
Rats, Mutant Strains | 1 | 1994 | 23 | 0.030 |
Why?
|
Patient Care Team | 1 | 2016 | 283 | 0.030 |
Why?
|
Radioimmunoassay | 3 | 1982 | 155 | 0.030 |
Why?
|
Urea | 2 | 2009 | 59 | 0.030 |
Why?
|
Neoplasms | 1 | 1989 | 3035 | 0.030 |
Why?
|
Animals, Newborn | 2 | 1986 | 524 | 0.030 |
Why?
|
Decision Support Techniques | 1 | 2015 | 167 | 0.030 |
Why?
|
Imaging, Three-Dimensional | 1 | 2017 | 595 | 0.030 |
Why?
|
Renal Insufficiency | 1 | 2013 | 98 | 0.030 |
Why?
|
Calcinosis | 1 | 2014 | 230 | 0.030 |
Why?
|
Carbohydrates | 4 | 1985 | 47 | 0.030 |
Why?
|
Chlorothiazide | 2 | 1982 | 5 | 0.030 |
Why?
|
Infant | 4 | 2013 | 3147 | 0.030 |
Why?
|
Malates | 1 | 1992 | 5 | 0.030 |
Why?
|
Cells, Cultured | 3 | 1988 | 2880 | 0.030 |
Why?
|
Acetazolamide | 2 | 1985 | 10 | 0.020 |
Why?
|
Electrochemistry | 1 | 1991 | 60 | 0.020 |
Why?
|
Natriuresis | 2 | 1986 | 29 | 0.020 |
Why?
|
Regression Analysis | 2 | 1998 | 590 | 0.020 |
Why?
|
Circular Dichroism | 1 | 1991 | 117 | 0.020 |
Why?
|
Sodium Chloride | 1 | 1991 | 88 | 0.020 |
Why?
|
Dihydroxycholecalciferols | 2 | 1981 | 10 | 0.020 |
Why?
|
Macromolecular Substances | 1 | 1991 | 177 | 0.020 |
Why?
|
Hydroxycholecalciferols | 2 | 1981 | 13 | 0.020 |
Why?
|
Methods | 2 | 1986 | 151 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 1992 | 1057 | 0.020 |
Why?
|
Rabbits | 1 | 1991 | 638 | 0.020 |
Why?
|
Chemistry, Physical | 1 | 1989 | 29 | 0.020 |
Why?
|
Centrifugation, Density Gradient | 1 | 1989 | 112 | 0.020 |
Why?
|
Chronic Disease | 3 | 1985 | 948 | 0.020 |
Why?
|
Infusions, Parenteral | 2 | 1985 | 51 | 0.020 |
Why?
|
Physicians | 1 | 1977 | 689 | 0.020 |
Why?
|
Thrombophlebitis | 1 | 1989 | 25 | 0.020 |
Why?
|
Adsorption | 1 | 1988 | 54 | 0.020 |
Why?
|
Antibodies | 1 | 1991 | 353 | 0.020 |
Why?
|
Cattle | 1 | 1989 | 375 | 0.020 |
Why?
|
Potassium Citrate | 1 | 2008 | 2 | 0.020 |
Why?
|
Microscopy, Polarization | 1 | 2008 | 10 | 0.020 |
Why?
|
Tissue and Organ Harvesting | 1 | 2009 | 78 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 1989 | 312 | 0.020 |
Why?
|
Ligands | 1 | 2009 | 443 | 0.020 |
Why?
|
Cerebrovascular Disorders | 1 | 1989 | 143 | 0.020 |
Why?
|
Methylation | 1 | 1968 | 268 | 0.020 |
Why?
|
Video Recording | 1 | 2008 | 203 | 0.020 |
Why?
|
Blood | 2 | 1982 | 69 | 0.020 |
Why?
|
Urography | 1 | 2007 | 45 | 0.020 |
Why?
|
Urinary Tract Infections | 3 | 1982 | 76 | 0.020 |
Why?
|
Urination Disorders | 1 | 2007 | 50 | 0.020 |
Why?
|
Iodohippuric Acid | 1 | 1966 | 2 | 0.020 |
Why?
|
Radioisotope Renography | 1 | 1966 | 7 | 0.020 |
Why?
|
Regeneration | 1 | 1967 | 150 | 0.020 |
Why?
|
Circadian Rhythm | 1 | 2009 | 305 | 0.020 |
Why?
|
Drinking | 1 | 2006 | 33 | 0.020 |
Why?
|
Pelvic Neoplasms | 1 | 1986 | 45 | 0.020 |
Why?
|
Cell Membrane Permeability | 1 | 1986 | 120 | 0.020 |
Why?
|
Atrial Function | 1 | 1986 | 19 | 0.020 |
Why?
|
Atrial Natriuretic Factor | 1 | 1986 | 39 | 0.020 |
Why?
|
Microelectrodes | 1 | 1986 | 83 | 0.020 |
Why?
|
Phase Transition | 1 | 2006 | 18 | 0.020 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2006 | 35 | 0.020 |
Why?
|
Pregnancy, Animal | 1 | 1986 | 58 | 0.020 |
Why?
|
Organ Culture Techniques | 1 | 1986 | 135 | 0.020 |
Why?
|
Chelating Agents | 1 | 2006 | 69 | 0.020 |
Why?
|
Surface Tension | 1 | 1985 | 8 | 0.020 |
Why?
|
Iodine Radioisotopes | 1 | 1966 | 134 | 0.020 |
Why?
|
Tissue Distribution | 1 | 1986 | 293 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 1986 | 308 | 0.020 |
Why?
|
Models, Theoretical | 1 | 1988 | 491 | 0.020 |
Why?
|
Hyperthyroidism | 1 | 1986 | 75 | 0.020 |
Why?
|
Egtazic Acid | 1 | 1985 | 33 | 0.020 |
Why?
|
Blood Gas Analysis | 1 | 1985 | 38 | 0.020 |
Why?
|
Prostheses and Implants | 1 | 1986 | 124 | 0.020 |
Why?
|
Living Donors | 1 | 2009 | 339 | 0.020 |
Why?
|
Microscopy, Immunoelectron | 1 | 2005 | 29 | 0.020 |
Why?
|
Sodium Azide | 1 | 1985 | 5 | 0.020 |
Why?
|
Sulfhydryl Compounds | 1 | 2006 | 71 | 0.020 |
Why?
|
Azides | 1 | 1985 | 11 | 0.020 |
Why?
|
Epithelium | 1 | 1986 | 325 | 0.020 |
Why?
|
Protein Biosynthesis | 1 | 1967 | 388 | 0.020 |
Why?
|
Freezing | 1 | 1985 | 32 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 1986 | 323 | 0.020 |
Why?
|
Myocardial Infarction | 1 | 1989 | 373 | 0.020 |
Why?
|
Brachytherapy | 1 | 1986 | 121 | 0.020 |
Why?
|
Systole | 1 | 2005 | 115 | 0.020 |
Why?
|
Maternal-Fetal Exchange | 1 | 1985 | 77 | 0.020 |
Why?
|
Electrolytes | 3 | 1982 | 52 | 0.020 |
Why?
|
Rectal Neoplasms | 1 | 1986 | 127 | 0.020 |
Why?
|
Diastole | 1 | 2005 | 141 | 0.020 |
Why?
|
Sheep | 1 | 1985 | 250 | 0.020 |
Why?
|
Metabolic Diseases | 2 | 1977 | 50 | 0.020 |
Why?
|
Thiourea | 1 | 1984 | 9 | 0.020 |
Why?
|
Prevalence | 1 | 2008 | 1240 | 0.020 |
Why?
|
Permeability | 1 | 1984 | 137 | 0.010 |
Why?
|
Osteomalacia | 2 | 1981 | 13 | 0.010 |
Why?
|
Tissue and Organ Procurement | 1 | 2009 | 345 | 0.010 |
Why?
|
Absorption | 1 | 1984 | 25 | 0.010 |
Why?
|
Malabsorption Syndromes | 2 | 1981 | 21 | 0.010 |
Why?
|
Blood Chemical Analysis | 1 | 1984 | 41 | 0.010 |
Why?
|
Age Distribution | 1 | 2004 | 200 | 0.010 |
Why?
|
Fibrosis | 1 | 2005 | 234 | 0.010 |
Why?
|
Infant, Newborn | 3 | 1978 | 2476 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2012 | 2335 | 0.010 |
Why?
|
Extracellular Space | 2 | 1986 | 92 | 0.010 |
Why?
|
Dogs | 3 | 1968 | 704 | 0.010 |
Why?
|
Biological Transport | 1 | 1983 | 401 | 0.010 |
Why?
|
Comorbidity | 1 | 2005 | 948 | 0.010 |
Why?
|
Software | 1 | 1986 | 665 | 0.010 |
Why?
|
Meat | 1 | 1981 | 27 | 0.010 |
Why?
|
Rickets | 1 | 1981 | 5 | 0.010 |
Why?
|
Smoking | 1 | 2005 | 620 | 0.010 |
Why?
|
Calcifediol | 1 | 1981 | 20 | 0.010 |
Why?
|
Hypoparathyroidism | 1 | 1981 | 24 | 0.010 |
Why?
|
Surveys and Questionnaires | 1 | 2009 | 2612 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2005 | 688 | 0.010 |
Why?
|
Nutrition Disorders | 1 | 1980 | 15 | 0.010 |
Why?
|
Sarcoidosis | 1 | 1981 | 72 | 0.010 |
Why?
|
Osteitis Fibrosa Cystica | 1 | 1980 | 4 | 0.010 |
Why?
|
Viomycin | 1 | 1980 | 1 | 0.010 |
Why?
|
Cellulose | 1 | 1980 | 55 | 0.010 |
Why?
|
Oxygen | 1 | 1985 | 742 | 0.010 |
Why?
|
Placebos | 1 | 1980 | 214 | 0.010 |
Why?
|
Tuberculosis, Pulmonary | 1 | 1980 | 58 | 0.010 |
Why?
|
Plasmapheresis | 1 | 1978 | 25 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1978 | 270 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2005 | 1239 | 0.010 |
Why?
|
Hypertrophy | 2 | 1968 | 67 | 0.010 |
Why?
|
Partial Pressure | 1 | 1977 | 50 | 0.010 |
Why?
|
Aldosterone | 1 | 1977 | 56 | 0.010 |
Why?
|
Molecular Conformation | 1 | 1977 | 96 | 0.010 |
Why?
|
Cystoscopy | 1 | 1977 | 39 | 0.010 |
Why?
|
Obstetric Labor, Premature | 1 | 1978 | 58 | 0.010 |
Why?
|
Gastric Mucosa | 1 | 1977 | 66 | 0.010 |
Why?
|
Guanethidine | 1 | 1977 | 3 | 0.010 |
Why?
|
Methyldopa | 1 | 1977 | 3 | 0.010 |
Why?
|
Syndrome | 1 | 1978 | 449 | 0.010 |
Why?
|
Dyspnea | 1 | 1977 | 75 | 0.010 |
Why?
|
Hydralazine | 1 | 1977 | 19 | 0.010 |
Why?
|
Constriction | 1 | 1976 | 27 | 0.010 |
Why?
|
Dehydration | 1 | 1976 | 20 | 0.010 |
Why?
|
Pedigree | 1 | 1979 | 969 | 0.010 |
Why?
|
Pregnancy Complications, Infectious | 1 | 1978 | 117 | 0.010 |
Why?
|
Models, Molecular | 1 | 1981 | 1296 | 0.010 |
Why?
|
Palliative Care | 1 | 1978 | 263 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 1978 | 995 | 0.010 |
Why?
|
Vomiting | 1 | 1977 | 194 | 0.010 |
Why?
|
Liver | 1 | 1981 | 1205 | 0.010 |
Why?
|
Diphosphates | 1 | 1975 | 18 | 0.010 |
Why?
|
Thyroidectomy | 1 | 1976 | 171 | 0.010 |
Why?
|
Methionine | 1 | 1975 | 65 | 0.010 |
Why?
|
Anticoagulants | 1 | 1978 | 426 | 0.010 |
Why?
|
Aorta | 1 | 1976 | 288 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 1977 | 783 | 0.010 |
Why?
|
Chondrocalcinosis | 1 | 1974 | 8 | 0.010 |
Why?
|
Osteoarthritis | 1 | 1974 | 74 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 1978 | 975 | 0.010 |
Why?
|
Crohn Disease | 1 | 1980 | 758 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 1977 | 1591 | 0.010 |
Why?
|
Spectrophotometry, Atomic | 1 | 1973 | 12 | 0.010 |
Why?
|
Uremia | 1 | 1973 | 14 | 0.010 |
Why?
|
Combined Modality Therapy | 2 | 1987 | 1710 | 0.010 |
Why?
|
Renin | 1 | 1973 | 67 | 0.010 |
Why?
|
Diagnostic Errors | 1 | 1974 | 160 | 0.010 |
Why?
|
Angiotensin II | 1 | 1973 | 93 | 0.010 |
Why?
|
Hospitalization | 1 | 1977 | 876 | 0.010 |
Why?
|
Glucosephosphate Dehydrogenase | 1 | 1968 | 18 | 0.010 |
Why?
|
Spectrophotometry | 1 | 1989 | 108 | 0.010 |
Why?
|
Urinary Catheterization | 1 | 1968 | 36 | 0.000 |
Why?
|
Tritium | 1 | 1967 | 133 | 0.000 |
Why?
|
Leucine | 1 | 1967 | 60 | 0.000 |
Why?
|
Colic | 1 | 1987 | 7 | 0.000 |
Why?
|
Dinitrophenols | 1 | 1967 | 7 | 0.000 |
Why?
|
Thiamine | 1 | 1967 | 8 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 1978 | 2411 | 0.000 |
Why?
|
Radiation Protection | 1 | 1986 | 26 | 0.000 |
Why?
|
Blood Proteins | 1 | 1967 | 145 | 0.000 |
Why?
|
Kidneys, Artificial | 1 | 1966 | 4 | 0.000 |
Why?
|
Radiometry | 1 | 1966 | 56 | 0.000 |
Why?
|
Catheters, Indwelling | 1 | 1986 | 113 | 0.000 |
Why?
|
Surgical Mesh | 1 | 1986 | 122 | 0.000 |
Why?
|
Body Weight | 1 | 1986 | 452 | 0.000 |
Why?
|
Neoplasm Invasiveness | 1 | 1986 | 576 | 0.000 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 1981 | 44 | 0.000 |
Why?
|
Arteries | 1 | 1982 | 180 | 0.000 |
Why?
|
Administration, Oral | 1 | 1982 | 682 | 0.000 |
Why?
|
Thermodynamics | 1 | 1981 | 311 | 0.000 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1986 | 1363 | 0.000 |
Why?
|
Pregnancy Trimester, Second | 1 | 1977 | 69 | 0.000 |
Why?
|
Parity | 1 | 1977 | 96 | 0.000 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 1977 | 109 | 0.000 |
Why?
|
Hemochromatosis | 1 | 1974 | 11 | 0.000 |
Why?
|
Gout | 1 | 1974 | 75 | 0.000 |
Why?
|
Iron | 1 | 1974 | 168 | 0.000 |
Why?
|
Diabetes Complications | 1 | 1974 | 170 | 0.000 |
Why?
|
Salicylates | 1 | 1966 | 25 | 0.000 |
Why?
|